PAVmed Inc
PAVM0.527USD
+0.001+0.23%
取引時間 （ET）15分遅れの株価
8.83M時価総額
0.12直近12ヶ月PER
詳細情報 PAVmed Inc 企業名
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.
企業情報
企業コードPAVM
会社名PAVmed Inc
上場日Jul 27, 2016
最高経営責任者「CEO」Dr. Lishan Aklog, M.D.
従業員数39
証券種類Ordinary Share
決算期末Jul 27
本社所在地360 Madison Avenue
都市NEW YORK
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号10017
電話番号12129494319
ウェブサイトhttps://pavmed.com/
企業コードPAVM
上場日Jul 27, 2016
最高経営責任者「CEO」Dr. Lishan Aklog, M.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael J. Glennon
Mr. Michael J. Glennon
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
81.67K
--
Dr. Lishan Aklog, M.D.
Dr. Lishan Aklog, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
78.72K
--
Mr. Ronald M. (Ron) Sparks
Mr. Ronald M. (Ron) Sparks
Independent Director
Independent Director
65.00K
--
Mr. Dennis M. Mcgrath
Mr. Dennis M. Mcgrath
President, Chief Financial Officer
President, Chief Financial Officer
50.83K
--
Mr. Sundeep Agrawal, M.D.
Mr. Sundeep Agrawal, M.D.
Director
Director
12.20K
--
Mr. Michael A. Gordon
Mr. Michael A. Gordon
General Counsel, Secretary
General Counsel, Secretary
--
--
Ms. Debra J. White
Ms. Debra J. White
Independent Director
Independent Director
--
--
Mr. Timothy (Tim) Baxter
Mr. Timothy (Tim) Baxter
Independent Director
Independent Director
--
--
Mr. Matt Riley
Mr. Matt Riley
Director of Investor Relations
Director of Investor Relations
--
--
Mr. Shaun M. O'Neil
Mr. Shaun M. O'Neil
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael J. Glennon
Mr. Michael J. Glennon
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
81.67K
--
Dr. Lishan Aklog, M.D.
Dr. Lishan Aklog, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
78.72K
--
Mr. Ronald M. (Ron) Sparks
Mr. Ronald M. (Ron) Sparks
Independent Director
Independent Director
65.00K
--
Mr. Dennis M. Mcgrath
Mr. Dennis M. Mcgrath
President, Chief Financial Officer
President, Chief Financial Officer
50.83K
--
Mr. Sundeep Agrawal, M.D.
Mr. Sundeep Agrawal, M.D.
Director
Director
12.20K
--
Mr. Michael A. Gordon
Mr. Michael A. Gordon
General Counsel, Secretary
General Counsel, Secretary
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, May 16
更新時刻: Fri, May 16
株主統計
種類
株主統計
株主統計
比率
Tasso Partners, LLC
14.61%
First Manhattan Co. LLC
4.05%
Dubreville (Anthony Michael)
3.44%
Pavilion Venture Partners, L.L.C.
1.69%
Geode Capital Management, L.L.C.
0.53%
Other
75.68%
株主統計
株主統計
比率
Tasso Partners, LLC
14.61%
First Manhattan Co. LLC
4.05%
Dubreville (Anthony Michael)
3.44%
Pavilion Venture Partners, L.L.C.
1.69%
Geode Capital Management, L.L.C.
0.53%
Other
75.68%
種類
株主統計
比率
Corporation
16.31%
Individual Investor
5.92%
Investment Advisor
5.88%
Investment Advisor/Hedge Fund
0.72%
Hedge Fund
0.19%
Research Firm
0.14%
Venture Capital
0.13%
Other
70.72%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
101
5.16M
29.28%
+2.77M
2025Q1
106
5.16M
31.74%
+3.03M
2024Q4
110
2.41M
17.67%
+156.53K
2024Q3
120
2.58M
24.42%
+197.13K
2024Q2
133
1.94M
20.61%
-301.78K
2024Q1
169
2.19M
26.52%
+433.78K
2023Q4
185
1.60M
20.86%
-48.73K
2023Q3
208
1.30M
18.00%
-268.87K
2023Q2
221
1.26M
18.65%
-731.24K
2023Q1
227
1.31M
20.36%
-649.18K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Tasso Partners, LLC
2.57M
14.61%
+2.57M
--
Feb 21, 2025
First Manhattan Co. LLC
714.10K
4.05%
+14.10K
+2.01%
Mar 31, 2025
Dubreville (Anthony Michael)
606.26K
3.44%
+606.26K
--
Aug 30, 2024
Pavilion Venture Partners, L.L.C.
297.11K
1.69%
--
--
Apr 22, 2025
Geode Capital Management, L.L.C.
92.67K
0.53%
+13.20K
+16.62%
Mar 31, 2025
Glennon (Michael J)
81.67K
0.46%
+1.00
+0.00%
Apr 22, 2025
The Vanguard Group, Inc.
81.49K
0.46%
--
--
Mar 31, 2025
Aklog (Lishan)
78.72K
0.45%
--
--
Apr 22, 2025
BlackRock Institutional Trust Company, N.A.
72.66K
0.41%
--
--
Mar 31, 2025
CAPTRUST Financial Advisors
65.05K
0.37%
+65.05K
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
日付
種類
比率
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
